Australis Scientific Wins 2025 MedTech Innovator Asia Pacific Grand Prize for Bladder Care Breakthrough
- Written by: Nick Agahari, Founder and CEO, Australis Scientific
Australis Scientific was founded with a clear mission: to make effective bladder care more accessible and empower people affected by overactive bladder (OAB) and urinary incontinence. That mission has now been recognised globally, with Australis Scientific named the 2025 MedTech Innovator Asia Pacific Grand Prize winner in Singapore.
Receiving this accolade, together with a USD $175,000 award, among an exceptional field of health technology pioneers is both humbling and energising. More importantly, it confirms the urgent need to modernise global bladder health management and gives us the visibility, credibility, and connections to accelerate our impact.
Our innovation, Confidanz™, is a discreet, band-aid-sized smart patch designed for people living with OAB and urinary incontinence, conditions that affect more than 400 million people worldwide. Worn near the ankle, the patch delivers gentle tibial nerve stimulation to calm bladder activity and reduce urgency, frequency, and leakage. Current treatments often depend on medications or invasive procedures that can cause side effects or create access barriers. Confidanz™ offers a simpler, home-based alternative that restores not just bladder control, but confidence and dignity.
By bringing proven clinical therapy into the home, Confidanz™ supports users with remote monitoring through a mobile app and telehealth platform. As economies age, particularly in markets like Japan where adult diapers now outsell infant ones and more than 12 million adults face bladder challenges, solutions that enable independence and reduce clinical reliance are becoming increasingly vital. These technologies also ease the burden on caregivers and healthcare systems that need effective, non-invasive tools.
We are currently conducting the SPARC Study, our first-in-human clinical trial, in Sydney and Brisbane. The findings will form the foundation for regulatory submissions in Australia, the United States, and Japan.
Healthcare innovation must ultimately be judged by its human impact. For our team and partners, that means transforming a daily struggle into a manageable condition for patients while supporting clinicians with accessible, evidence-based solutions. As one early participant shared, “Confidanz™ helped me regain confidence in daily life without relying on drugs.” It is stories like this that drive us forward.
As we scale our technology across the Asia Pacific and beyond, we invite investors, clinicians, and collaborators to join us in redefining what is possible in bladder health. Together, we can deliver lasting improvements in quality of life and shape a more inclusive future for healthcare.
About the Author:
Nick Agahari is the Founder and CEO of Australis Scientific, a Sydney-based medtech company developing innovative wearable therapies for bladder health. A Harvard Medical School HealthTech Fellow, Nick is passionate about advancing accessible, evidence-based care that improves quality of life for people around the world.
